A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
Public ClinicalTrials.gov record NCT05051579. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities
Study identification
- NCT ID
- NCT05051579
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 272 participants
Conditions and interventions
Conditions
Interventions
- LY3502970 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 28, 2021
- Primary completion
- Aug 24, 2022
- Completion
- Nov 21, 2022
- Last update posted
- Sep 12, 2023
2021 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials, LLC | Anaheim | California | 92801 | — |
| John Muir Physician Network Research Center | Concord | California | 94520 | — |
| NorCal Medical Research, Inc | Greenbrae | California | 94904 | — |
| Valley Clinical Trials, Inc. | Northridge | California | 91325 | — |
| Norcal Endocrinology & Internal Medicine | San Ramon | California | 94583 | — |
| Elite Clinical Trials | Blackfoot | Idaho | 83221 | — |
| Rocky Mountain Clinical Research | Idaho Falls | Idaho | 83404 | — |
| StudyMetrix Research | City of Saint Peters | Missouri | 63303 | — |
| Premier Research | Trenton | New Jersey | 08611 | — |
| Lillestol Research | Fargo | North Dakota | 58104 | — |
| Intend Research, LLC | Norman | Oklahoma | 73069 | — |
| Capital Area Research, LLC | Camp Hill | Pennsylvania | 17011 | — |
| Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair | Pittsburgh | Pennsylvania | 15243 | — |
| Dallas Diabetes Research Center | Dallas | Texas | 75230 | — |
| Diabetes and Thyroid Center of Fort Worth | Fort Worth | Texas | 76132 | — |
| Texas Diabetes & Endocrinology, P.A. | Round Rock | Texas | 78681 | — |
| National Clinical Research, Inc | Richmond | Virginia | 23294 | — |
| St. Vincent Hospital d/b/a Prevea Health | Green Bay | Wisconsin | 54303 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05051579, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 12, 2023 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05051579 live on ClinicalTrials.gov.